Pharmaceuticals APAC News & Press Release Distribution

Tang Prize Laureates Reflect on the Breakthroughs Made Possible by Cytokine Research

TAIPEI, Nov. 27, 2021 /PRNewswire/ -- Following the inspiring opening speech, "Future Perspective of Cancer Immunotherapy," delivered by Nobel Prize and Tang Prize laureate Prof.Tasuku Honjo at the 14th Asia Pacific Federation of Pharmacologist Conference (APFP) onNovember 26, the 2020 Tang Prize...

2021-11-27 16:00 4621

Róbert Wessman-led Aztiq and Innobic join forces in $475m acquisition of Lotus Pharmaceutical and Adalvo to create a global pharmaceutical powerhouse

REYKJAVÍK, Iceland, Nov. 26, 2021 /PRNewswire/ -- Aztiq ("Aztiq"), a healthcare investor led by Alvogen Founder and Chairman Róbert Wessman, andInnobic (Asia) Company Limited ("Innobic"), a life sciences subsi...

2021-11-26 15:51 2452

Róbert Wessman-led Aztiq and Innobic join forces in $475m acquisition of Lotus Pharmaceutical and Adalvo to create a global pharmaceutical powerhouse

Starpharma releases positive DEP® phase 2 interim results in prostate cancer

MELBOURNE, Australia, Nov. 26, 2021 /PRNewswire/ -- Melbourne biotech company Starpharma today announced positive interim results from the prostate cancer cohort in its ongoing phase 2 trial of DEP® cabazitaxel. The company showed that 100% of evaluable patients with (Stage IV) metastatic prostat...

2021-11-26 15:41 2031

Premium Red Ginseng Brand CheongKwanJang to Celebrate 122nd anniversary

SEOUL, South Korea, Nov. 26, 2021 /PRNewswire/ -- Korea Ginseng Corp (KGC) celebrates the 122nd anniversary of its premium red ginseng brand, CheongKwanJang. Red Ginseng One of the best ginseng in the world, Korean ginseng became a premi...

2021-11-26 15:37 2800

Premium Red Ginseng Brand CheongKwanJang to Celebrate 122nd anniversary

SEOUL, South Korea, Nov. 26, 2021 /PRNewswire/ -- Korea Ginseng Corp (KGC) celebrates the 122nd anniversary of its premium red ginseng brand, CheongKwanJang. Korean Ginseng One of the best ginseng in the world, Korean ginseng became a...

2021-11-26 15:28 3103

Henlius Novel Anti PD-L1/TIGIT Bispecific Antibody Received Clinical Trial Approval in Australia

SHANGHAI, Nov. 25, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the filing of a clinical trial for HLX301, a Recombinant Humanized Anti-PDL1 and Anti-TIGIT Bispecific Antibody, in Patients with locally advanced or metastatic solid tumours has been approved by the ...

2021-11-25 17:27 2952

Innovative €250,000 Parenteral Nutrition Research Grant Awarded by Fresenius Kabi

BAD HOMBURG, Germany, Nov. 25, 2021 /PRNewswire/ -- Fresenius Kabi was delighted to announce the winner of their innovative JUMPstart education program and research grant onSeptember 10, 2021. JUMPstart is an initiative that aims to nurture research in the field of parenteral nutrition through th...

2021-11-25 15:45 2647

Innovative €250,000 Parenteral Nutrition Research Grant Awarded by Fresenius Kabi

Sartorius significantly expands activities in South Korea

SHANGHAI, Nov. 25, 2021 /PRNewswire/ -- The life science company Sartorius is investing around270 million euros, some 300 million U.S. dollars, through the end of 2024 in expanding its activities inSouth Korea. In the country's biopharma hub Songdo in Incheon, the company plans to launch cell cul...

2021-11-25 12:42 1813

iX Biopharma Signs Exclusive License Agreement For Wafermine And Other Sublingual Ketamine Wafer Products

* iX Biopharma will receive an initial US$9 million upfront payment * Eligible for up to US$239 million in development and sales milestone payments * Double digit royalties on future product sales of any licensed product SINGAPORE, Nov. 25, 2021 /PRNewswire/ -- iX Biopharma Ltd (SGX:42C), a ...

2021-11-25 00:18 2704

Mannin GmbH Implements CDD Vault Informatics Platform to Facilitate Data Management and Collaboration

LEIPZIG, Germany and SAN FRANCISCO, Nov. 24, 2021 /PRNewswire/ -- Mannin GmbH, a biotechnology company specializing in the research and development for new vascular therapeutics, announced today that it has implemented CDD Vault in its Leipzig laboratories. CDD Vault, a hosted chemistry and biolog...

2021-11-24 13:57 1502

IND Application for Phase 3 Registration Study of KN046 in Combination with Chemotherapy for the Treatment of Pancreatic Cancer was Approved by CDE

SUZHOU, China, Nov. 24, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the IND application for phase 3 registration study (KN046-303) of the PD-L1/CTLA-4 bispecific antibody KN046 plus nab-paclitaxel/gemcitabine for the treatment of advanced pancreatic ductal adenoca...

2021-11-24 09:35 2150

Everest Medicines Announces Inclusion in the MSCI Global Small Cap Indexes - MSCI China Index

SHANGHAI, Nov. 24, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inAsia, today announced that th...

2021-11-24 08:00 2255

Seegene Announces Q3 2021 Earnings, Continuing COVID-Era Momentum

* Q3 Revenue held steady at KRW 305.3 billion * Operating profit dipped slight due to powerful investment in R&D * Scheduled to introduce new diagnostic tests capable of screening 22 targets, including3 genes of COVID-19 and 19 respiratory viruses in a single tube SEOUL, South Korea, Nov. 2...

2021-11-23 16:03 1612

PromarkerD distribution network expands to Britain

* World's first predictive diagnostic test for diabetic kidney disease to be sold inGreat Britain under distribution deal with global diagnostic distributor, Apacor Limited * Apacor will become the exclusive distributor for PromarkerD in Great Britain (England, Scotland and Wales) * Estimat...

2021-11-23 11:56 1648

EZZ accelerates genomic health focus with launch of two new biotic products

SYDNEY, Nov. 23, 2021 /PRNewswire/ -- EZZ Life Science Holdings Limited (ASX: EZZ),an Australian genomic life science company with a mission to improve quality of life and human health, is pleased to have added two new consumer health products to its range, to be sold in pharmacies acrossAustrali...

2021-11-23 04:00 1605

EZZ accelerates genomic health focus with launch of two new biotic products

Innovent Releases the ORIENT-31 Phase 3 Study First Interim Analysis Results of Sintilimab plus BYVASDA (bevacizumab biosimilar injection) and Chemotherapy in Patients with EGFR-mutated Nonsquamous Non-small Cell Lung Cancer who Progressed After EGFR-TKI Therapy at ESMO Virtual Plenary 2021

SAN FRANCISCO and SUZHOU, China, Nov. 22, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...

2021-11-22 08:16 2582

Innovent Announces Inclusion of the Company's Stock (01801.HK) in the Hang Seng China Enterprises Index

SAN FRANCISCO and SUZHOU, China, Nov. 22, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...

2021-11-22 08:00 3141

CStone Pharmaceuticals and Jiangsu Hengrui Pharmaceuticals announce strategic partnership and exclusive licensing agreement on anti-CTLA-4 monoclonal antibody CS1002 in Greater China

SUZHOU, China, Nov. 21, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, and Jiangsu Hengrui Pharmaceuticals ("Hengru...

2021-11-21 17:09 2957

Brii Biosciences Joins Hang Seng Composite Index

DURHAM, N.C. and BEIJING, Nov. 19, 2021 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), today announced that Brii Biosciences has been included as a constituent stock of the Hang Seng Composite Index. Dr. Ankang L...

2021-11-19 19:06 2992

YHLO Revealed Its New Development of CLIA Technology at MEDICA 2021

DUSSELDORF, Germany, Nov. 19, 2021 /PRNewswire/ -- Shenzhen YHLO Biotech Co., Ltd (688575.SSE), an innovative and steadfastly growing company of immunoassay solutions, presented its compact and automated chemiluminescence immunoassay (CLIA) analyzer iFlash 1200 at Medica 2021, a world-renowned tr...

2021-11-19 14:43 1557